In Thursday’s Wall Street session, Chimerix Inc (NASDAQ:CMRX) shares traded at $8.43, down -0.35% from the previous session.
CMRX stock price is now 100.86% away from the 50-day moving average and 366.83% away from the 200-day moving average. The market capitalization of the company currently stands at $758.16M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $7, Robert W. Baird recently initiated with Outperform rating for Chimerix Inc (NASDAQ: CMRX). On September 07, 2022, CapitalOne recently initiated its ‘Overweight’ rating on the stock quoting a target price of $7, while ‘Maxim Group’ rates the stock as ‘Buy’
In other news, Melemed Allen S., CHIEF MEDICAL OFFICER sold 3,065 shares of the company’s stock on Feb 13 ’25. The stock was sold for $13,799 at an average price of $4.50. Upon completion of the transaction, the CHIEF MEDICAL OFFICER now directly owns 152,875 shares in the company, valued at $1.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 13 ’25, PRESIDENT AND CEO Andriole Michael T. sold 7,370 shares of the business’s stock. A total of $33,282 was realized by selling the stock at an average price of $4.52. This leaves the insider owning 609,603 shares of the company worth $5.14 million. A total of 15.43% of the company’s stock is owned by insiders.
During the past 12 months, Chimerix Inc has had a low of $0.75 and a high of $8.47. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 6.33, and a quick ratio of 6.33.
The net profit margin was -52574.84% and return on equity was -48.59% for CMRX. The company reported revenue of $26000.0 for the quarter, compared to $11000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 136.36 percent.
